Search Results - Giles Robinson
- Showing 1 - 20 results of 51
- Go to Next Page
-
1
Role of MYC in Medulloblastoma by Martine F. Roussel, Giles Robinson
Published 2013Revisão -
2
-
3
-
4
-
5
-
6
Zeb1 controls neuron differentiation and germinal zone exit by a mesenchymal-epithelial-like transition by Shalini Singh, Danielle Howell, Niraj Trivedi, Ketty Kessler, Taren Ong, Pedro Rosmaninho, Alexandre A. S. F. Raposo, Giles Robinson, Martine F. Roussel, Diogo S. Castro, David J. Solecki
Published 2016Artigo -
7
-
8
A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma by Daisuke Kawauchi, Giles Robinson, Tamar Uziel, Paul Gibson, Jerold E. Rehg, Cuilan Gao, David Finkelstein, Chunxu Qu, Stanley Pounds, David W. Ellison, Richard J. Gilbertson, Martine F. Roussel
Published 2012Artigo -
9
Primary cilia control translation and the cell cycle in medulloblastoma by Yong Ha Youn, Shirui Hou, Chang‐Chih Wu, Daisuke Kawauchi, Brent A. Orr, Giles Robinson, David Finkelstein, Makoto M. Taketo, Richard J. Gilbertson, Martine F. Roussel, Young-Goo Han
Published 2022Artigo -
10
Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study by Raja B. Khan, Zoltán Patay, Paul Klimo, Jie Huang, Rahul Kumar, Frederick A. Boop, Darcy Raches, Heather M. Conklin, Richa Sharma, Andrea Simmons, Zsila Sadighi, Arzu Onar‐Thomas, Amar Gajjar, Giles Robinson
Published 2021Artigo -
11
Lorlatinib in a Child with <i>ALK</i>-Fusion–Positive High-Grade Glioma by Aditi Bagchi, Brent A. Orr, Olivia Campagne, Sandeep Kumar Dhanda, Sreenath Nair, Quynh T. Tran, Anthony M. Christensen, Amar Gajjar, Larissa V. Furtado, Aksana Vasilyeva, Frederick A. Boop, Clinton F. Stewart, Giles Robinson
Published 2021Carta -
12
MRI identifies disrupted cerebral development in medulloblastoma patients by Asim K. Bag, Joseph L. Holtrop, John O. Glass, Samuel S. McAfee, Shengjie Wu, Yimei Li, Matthew Scoggins, Silu Zhang, Giles Robinson, Amar Gajjar, Tara M. Brinkman, Heather M. Conklin, Wilburn E. Reddick
Published 2025Artigo -
13
Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor by Giles Robinson, Sue C. Kaste, Wassim Chemaitilly, Daniel C. Bowers, Stephen Laughton, Amy Smith, Nicholas G. Gottardo, Sonia Partap, Anne Bendel, Karen Wright, Brent A. Orr, William C. Warner, Arzu Onar‐Thomas, Amar Gajjar
Published 2017Artigo -
14
mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma by Chang-Chih Wu, Shirui Hou, Brent A. Orr, Bryan Kuo, Yong Ha Youn, Taren Ong, Fanny Roth, Charles G. Eberhart, Giles Robinson, David J. Solecki, Makoto M. Taketo, Richard J. Gilbertson, Martine F. Roussel, Young-Goo Han
Published 2017Artigo -
15
Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002) by Theodore Nicolaides, Kellie J. Nazemi, John R. Crawford, Lindsay Kilburn, Jane E. Minturn, Amar Gajjar, Karen Gauvain, Sarah Leary, Girish Dhall, Mariam Aboian, Giles Robinson, Janel Long‐Boyle, Hechuan Wang, Annette M. Molinaro, Sabine Mueller, Michael D. Prados
Published 2020Artigo -
16
Comprehensive analysis of <i>MYB/MYBL1</i>-altered pediatric-type diffuse low-grade glioma by Daniel C. Moreira, Ibrahim Qaddoumi, Susan Spiller, Thomas W. Bouldin, Alan Davidson, Nasjla Saba‐Silva, Daniel V Sullivan, Ryuma Tanaka, Aaron S. Wagner, Matthew D. Wood, Paul Klimo, Godwin Job, Meenakshi Devidas, Xiaoyu Li, Amar Gajjar, Giles Robinson, Jason Chiang
Published 2024Artigo -
17
Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children’s Oncology Group (ACNS1221) by Lucie Lafay‐Cousin, Éric Bouffet, Douglas Strother, Vasilisa A. Rudneva, Cynthia Hawkins, Charles G. Eberhart, Craig Horbinski, Linda Heier, Mark M. Souweidane, Chris Williams‐Hughes, Arzu Onar‐Thomas, Catherine A. Billups, Maryam Fouladi, Paul A. Northcott, Giles Robinson, Amar Gajjar
Published 2019Artigo -
18
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors by Birgit Geoerger, Franck Bourdeaut, Steven G. DuBois, Matthias Fischer, James I. Geller, Nicholas G. Gottardo, Aurélien Marabelle, Andrew D.J. Pearson, Shakeel Modak, Thomas F. Cash, Giles Robinson, Marlyane Motta, Alessandro Matano, Suraj G. Bhansali, Jason R. Dobson, Sudha Parasuraman, Susan Chi
Published 2017Artigo -
19
The Role of Inherited TPMT and COMT Genetic Variation in Cisplatin-Induced Ototoxicity in Children With Cancer by Jun J. Yang, Jiahui Lim, Jie Huang, Johnnie K. Bass, Jianrong Wu, C Wang, Jie Fang, Elizabeth Stewart, Elaine Harstead, Sánchez Casado E, Giles Robinson, William E. Evans, Alberto S. Pappo, Jian Zuo, Mary V. Relling, Arzu Onar‐Thomas, Amar Gajjar, Clinton F. Stewart
Published 2013Artigo -
20
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss by Heng Xu, Giles Robinson, Jie Huang, Joshua Yew-Suang Lim, Hui Zhang, Johnnie K. Bass, Alberto Broniscer, Murali Chintagumpala, Ute Bartels, S. Gururangan, Tim Hassall, Michael J. Fisher, Richard J. Cohn, Tetsuji Yamashita, Tal Teitz, Jian Zuo, Arzu Onar‐Thomas, Amar Gajjar, Clinton F. Stewart, Jun Yang
Published 2015Artigo
Search Tools:
Related Subjects
Biology
Medicine
Genetics
Medulloblastoma
Gene
Internal medicine
Cancer research
Oncology
Pathology
Cancer
Bioinformatics
Chemotherapy
Signal transduction
Sonic hedgehog
Cell biology
Computational biology
Gene expression
Mutation
Biochemistry
Glioma
Genome
Hedgehog
Neuroscience
Pediatrics
Prospective cohort study
Wnt signaling pathway
Carcinogenesis
Cell
Cell cycle
Cisplatin